Thus, the low-risk MDS groups (including RCMD) showed over-expression of VEGF (Figure 3B), HIF and FN1 (Figure S2) with respect to the control group (p<0.05). This evidence concerns the gene VEGFA and myelodysplastic syndrome with multilineage dysplasia.